If I look generally across our business, you can see some core, midsize brands performing well, Lovaza, Avodart, Arixtra, and in particular also you see ...
GlaxoSmithKline has announced that it will begin marking its drug Avodart at its facility in Poland. Point-of-care-testing firm Quidel has announced that it ...